Matt Theisen

机构：Moderna Therapeutics (United States)

发表论文 5 篇 · 总被引 497 次 · h-index 4

代表论文

• Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia (2017 · Cell Reports · 被引 265)
• Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates (2019 · The American Journal of Human Genetics · 被引 168)
• Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice (2022 · Molecular Therapy — Nucleic Acids · 被引 39)
• Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia (2018 · Cell Reports · 被引 25)
• Systemic mRNA therapy for the treatment of Fabry disease: Preclinical studies in GLA-deficient mice and rats, and wild-typenon-human primates (2018 · Molecular Genetics and Metabolism)